140 related articles for article (PubMed ID: 7791547)
1. Spin-lattice relaxation and magnetization transfer in intracranial tumors in vivo: effects of Gd-DTPA on relaxation parameters.
Kurki T; Komu M
Magn Reson Imaging; 1995; 13(3):379-85. PubMed ID: 7791547
[TBL] [Abstract][Full Text] [Related]
2. Tissue characterization of intracranial tumors by magnetization transfer and spin-lattice relaxation parameters in vivo.
Kurki T; Lundbom N; Komu M; Kormano M
J Magn Reson Imaging; 1996; 6(4):573-9. PubMed ID: 8835948
[TBL] [Abstract][Full Text] [Related]
3. Synergistic enhancement of MRI with Gd-DTPA and magnetization transfer.
Tanttu JI; Sepponen RE; Lipton MJ; Kuusela T
J Comput Assist Tomogr; 1992; 16(1):19-24. PubMed ID: 1729300
[TBL] [Abstract][Full Text] [Related]
4. T1 and T2 measurements of meningiomas and neuromas before and after Gd-DTPA.
Watabe T; Azuma T
AJNR Am J Neuroradiol; 1989; 10(3):463-70. PubMed ID: 2546413
[TBL] [Abstract][Full Text] [Related]
5. MR of intracranial tumors: combined use of gadolinium and magnetization transfer.
Kurki T; Niemi P; Valtonen S
AJNR Am J Neuroradiol; 1994 Oct; 15(9):1727-36. PubMed ID: 7847221
[TBL] [Abstract][Full Text] [Related]
6. Gadolinium-enhanced magnetization transfer contrast imaging of intracranial tumors.
Kurki TJ; Niemi PT; Lundbom N
J Magn Reson Imaging; 1992; 2(4):401-6. PubMed ID: 1633392
[TBL] [Abstract][Full Text] [Related]
7. Improvement of brain lesion detection at 0.1 T by simultaneous use of Gd-DTPA and magnetization transfer imaging.
Ramadan UA; Aronen HJ; Tanttu JI; Karjalainen PT; Kairemo KJ; Jääskeläinen J; Sipilä L; Häkkinen AM
Magn Reson Med; 1997 Feb; 37(2):268-74. PubMed ID: 9001152
[TBL] [Abstract][Full Text] [Related]
8. T1 and T2 relaxation times on gadolinium-diethylenetriaminepentaacetic acid enhanced magnetic resonance images of brain tumors.
Yamada S; Kubota R; Yamada K; Ono S; Hishinuma T; Matsuzawa T; Fujiwara S
Tohoku J Exp Med; 1990 Feb; 160(2):145-8. PubMed ID: 2353348
[TBL] [Abstract][Full Text] [Related]
9. Gd DTPA. Clinical efficacy.
Runge VM; Schaible TF; Goldstein HA; Wood ML; Haughton VM; Maravilla KR; Weinstein MA; Price AC; Wolpert SM; Kaufman D
Radiographics; 1988 Jan; 8(1):147-59. PubMed ID: 3353531
[TBL] [Abstract][Full Text] [Related]
10. The utility of contrast media in MRI at 0.02 T. A preliminary report.
Kormano M; Niemi P; Paajanen H; Määttänen H; Katevuo K
Invest Radiol; 1988 Sep; 23 Suppl 1():S289-91. PubMed ID: 3198364
[TBL] [Abstract][Full Text] [Related]
11. Transfer index of MR relaxation enhancer: a quantitative evaluation of MR contrast enhancement.
Kaneoke Y; Furuse M; Yoshida K; Saso K; Ichihara K; Motegi Y
AJNR Am J Neuroradiol; 1989; 10(2):329-33. PubMed ID: 2494852
[TBL] [Abstract][Full Text] [Related]
12. Sensitivity of Gd-DTPA-enhanced MR imaging of benign extraaxial tumors.
Haughton VM; Rimm AA; Czervionke LF; Breger RK; Fisher ME; Papke RA; Hendrix LE; Strother CM; Turski PA; Williams AL
Radiology; 1988 Mar; 166(3):829-33. PubMed ID: 3340779
[TBL] [Abstract][Full Text] [Related]
13. [Gadolinium DTPA in magnetic resonance. Clinical experience in intracranial pathology].
Bradac GB; Riva A; Berger T; Stura G; Duca S
Radiol Med; 1988; 76(1-2):33-7. PubMed ID: 3399707
[TBL] [Abstract][Full Text] [Related]
14. Spin echo and inversion recovery sequences for gadolinium-DTPA enhanced magnetic resonance imaging of intracranial tumors.
Laniado M; Niendorf HP; Schörner W; Felix R
Acta Radiol Suppl; 1986; 369():469-71. PubMed ID: 2980530
[TBL] [Abstract][Full Text] [Related]
15. [Changes in tissue T1 of brain tumor following GD-DTPA administration--differences in T1 time course and tissue-blood ratio by histological types].
Yoshida K; Furuse M; Kaneoke Y; Sasou K; Motegi Y
No To Shinkei; 1988 Jun; 40(6):531-7. PubMed ID: 3224029
[TBL] [Abstract][Full Text] [Related]
16. Magnetization transfer contrast in Gd-DTPA-enhanced imaging of brain tumors.
Niemi P; Kurki T; Lundbom N; Kormano M
Invest Radiol; 1991 Nov; 26 Suppl 1():S248-9; discussion S253-4. PubMed ID: 1808140
[No Abstract] [Full Text] [Related]
17. [Acoustic neurinomas. Magnetic resonance tomography using the contrast medium Gd-DTPA].
Pronin IN; Kornienko VN
Zh Vopr Neirokhir Im N N Burdenko; 1995; (2):16-7. PubMed ID: 7625134
[TBL] [Abstract][Full Text] [Related]
18. Assessment of T1 time course changes and tissue-blood ratios after Gd-DTPA administration in brain tumors.
Yoshida K; Furuse M; Kaneoke Y; Saso K; Inao S; Motegi Y; Ichihara K; Izawa A
Magn Reson Imaging; 1989; 7(1):9-15. PubMed ID: 2918823
[TBL] [Abstract][Full Text] [Related]
19. Gd-DTPA administered MR imaging of intracranial mass lesions: a comparison with CT and precontrast MR.
Mihara F; Hirakata R; Hasuo K; Yasumori K; Yoshida K; Kuroiwa T; Masuda K; Fukui M
Radiat Med; 1989; 7(5):227-35. PubMed ID: 2629036
[TBL] [Abstract][Full Text] [Related]
20. Magnetic resonance imaging of intracranial tumors using gadolinium-DTPA. Initial experience with fast imaging.
Niendorf HP; Felix R; Laniado M; Schörner W; Kornmesser W; Claussen C
Acta Radiol Suppl; 1986; 369():561-3. PubMed ID: 2980558
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
